Arcturus Therapeutics (NASDAQ:ARCT) traded lower on Friday after Citi downgraded the San Diego, California-based biotech, citing mid-stage data the company posted this week for ARCT-032, a messenger ...

Arcturus Therapeutics' interim Phase 2 CF data fell short of expectations, leading to a justified ~50% stock drop and ongoing caution. ARCT-032 showed no meaningful FEV1 improvement in CF patients, ...

SAN DIEGO, October 28, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of ...

There are few things in life more simple yet versatile than a tarp. Essentially, it is a large sheet of waterproof material, usually made of polyethylene, vinyl, or canvas, that is as durable as it is ...

SAN DIEGO, November 04, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of ...

The weekly rent for 178 Arcturus Drive, Kalkallo is $540 per week. When is 178 Arcturus Drive, Kalkallo available to rent? 178 Arcturus Drive, Kalkallo is available to rent now. How much is the rental ...

A festive weekend trip turned terrifying for Hyderabad-Bengaluru bus passengers as flames engulfed their vehicle. Survivors recounted harrowing escapes, using fists and laptops to break windows and ...

Investing.com - H.C. Wainwright downgraded Arcturus Therapeutics (NASDAQ:ARCT) from Buy to Neutral and set a price target of $12.00, citing concerns about the company’s cystic fibrosis (CF) program.